We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

MP BIOMEDICALS LLC

MP Biomedicals manufactures and sells a comprehensive line of in-vitro diagnostics solutions to hospitals and clinica... read more Featured Products: More products

Download Mobile App





MP Biomedicals Exhibits Diagnostics Kits and Sample Prep Solutions at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 24 Jun 2021
MP Biomedicals (Irvine, CA, USA) exhibited its range of diagnostics kits and sample prep solutions at MEDLAB Middle East 2021.

At this year’s edition of MEDLAB Middle East 2021, the company presented the FastPrep family of homogenizers - a comprehensive laboratory solution that optimizes the lysis, grinding, or homogenization process from virtually any sample type. More...
Mechanical lysis disrupts cells and tissues for the isolation of DNA, RNA, proteins, metabolites, and other small molecules, and eliminates the need for chemicals, enzymes, and detergents, which can inhibit some downstream processes. FastPrep instruments, Lysing Matrix tubes, and kits work together to deliver rapid, consistent, and efficient lysis and homogenization, resulting in high yields of purified nucleic acid or protein. A benchtop instrument utilizing bead-beating technology, the FastPrep provides complete and quantitative lysis of difficult and routine samples and is suitable in all applications that require grinding, lysing, or homogenization.

MP Biomedicals also showcased the AutoBlot System 36, an intelligent Western Blot processor that enables automated washing and incubation of up to 36 assay strips per run at pre-selected temperature. The AutoBlot System 36 helps to satisfy Immunoblot needs by minimizing human error, increasing productivity, and delivering accurate and consistent results.

Among its range of diagnostics kits, the company featured the Rapid SARS-CoV-2 Antigen Test Card which is a rapid, chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present on human nasal, nasopharyngeal or oropharyngeal swab specimens. Other products exhibited at the event included the Helico Blot 2.1 qualitative Western Blot Assay for the detection of IgG antibodies to H. pylori in human serum or plasma; ELISA and RIA new born screening panel for earlier diagnosis to confirm if a newborn requires essential medical intervention; HIV Blot 2.2 immunoblot for the in-vitro detection of antibodies to HIV in human serum or plasma samples; HTLV Blot 2.4 for the in-vitro detection of antibodies to HTLV-I and HTLV-II in human serum or plasma; HCV Blot 3.0 qualitative line blot immunoassay for the detection of antibodies to HCV; and the fully automated and integrated MPure-12 nucleic acid purification system to purify nucleic acids of the highest yield and purity for downstream applications.

Related Links:
MP Biomedicals


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Nutating Mixer
Enduro MiniMix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.